MICROVASCULAR TISSUES, INC.
Jamaica Plain, MA · Founded 2014 · CIK 0001607334 · Medtech · Private
Lyophilized allogeneic microvascular tissue graft (mVASC) that serves as a scaffold for capillary growth and improved blood flow to treat diabetic peripheral neuropathy
microvasculartissues.com →- Grants
- $350K
- 1 award
- Sector median: 1
- Raised
- $12M
- 5 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 9 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $2,332,000 | |
| Private capital raised | Form D · SEC | $3,500,000 | |
| Private capital raised | Form D · SEC | $4,112,304 | |
| Federal grant | Department of Health and Human Services · Phase I · Evaluating the Effect of a Local Microvascular Tissue Graft Treatment in Rat Models of Diabetic Peripheral Neuropathy | $350,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 798 | I-O Urology Corp | — | $16M |
| 799 | ChemoMouthpiece, LLC | — | $16M |
| 800 | Tulavi Therapeutics, Inc. | — | $13M |
| 801 | MICROVASCULAR TISSUES, INC. | — | $12M |
| 802 | THERAHEART INC. | — | $12M |
| 803 | LADERX LLC | — | $67K |
| 804 | AVEERA MEDICAL INC. | — | $8.8M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brent AtkinsonExecutive Officer
- Glen GongDirector · Executive Officer
- GLEN GONGDirector · Executive Officer
- Kevin OhashiDirector
- KEVIN OHASHIDirector
- Kevin OshasiDirector · Executive Officer
- Dale PetersonDirector · Executive Officer
- DALE PETERSONDirector
Patents
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseaseapplication
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Allogeneic Microvascular Tissue For Soft Tissue Treatmentsapplication
- Allogeneic Microvascular Tissue For Soft Tissue Treatmentsgranted
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Compositions And Methods For Treating Nerve Injuryapplication
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Compositions And Methods For Treating And Preventing Tissue Injury And Diseasegranted
- Enhanced Multipotent Cells And Microvascular Tissue And Methods Of Use Thereofapplication
- Allogeneic Microvascular Tissue For Soft Tissue Treatmentsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.